Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912177640> ?p ?o ?g. }
- W2912177640 endingPage "65" @default.
- W2912177640 startingPage "61" @default.
- W2912177640 abstract "There are only limited studies on perampanel (PER), one of the latest antiepileptic drug. This study aimed to evaluate the long-term efficacy and tolerability of perampanel as an add-on therapy in patients with intractable focal epilepsy.The medical records of 97 patients (age, 12-30 years) were retrospectively reviewed and analyzed. The patients had been diagnosed with focal epilepsy, treated with PER, and regularly followed up over 12 months.All patients had uncontrolled seizures despite treatment with two or more antiepileptic drugs. The mean age of seizure onset was 5.2 years (range, 0-17.0). PER was first prescribed at an average age of 15.7 years (range, 12.0-25.3), and mean follow-up duration after PER initiation was 15.9 months (range, 12-20). The responder rate was 41.7%, with over 75% seizure reduction obtained in 11 cases (15.3%), including three seizure-free cases (4.2%). The retention rates at 3, 6, 12, and 18 months of follow-up were 82.5% (80/97), 72.1% (70/97), 60.8% (59/97), and 37.5% (6/16), respectively. Forty-four patients (44/97, 45.4%) discontinued PER, because of treatment-related adverse events in 20 (20.6%) and no efficacy in 24 (24.7%). Treatment-related adverse events were reported by 52 patients (53.6%). The most common adverse event was somnolence or lethargy, reported by 17 patients (17/97, 23%), followed by dizziness (15/97, 20%) and psychological problems such as aggressiveness or irritability (15/97, 20%). Thirty-three patients (33/52, 63.4%) showed their first adverse symptom for 2 or 4 mg/day of PER.PER would be an effective therapeutic option for patients with intractable focal epilepsy. However, careful monitoring of adverse events is essential from treatment initiation, with particular attention to psychological problems in adolescents and young adults." @default.
- W2912177640 created "2019-02-21" @default.
- W2912177640 creator A5010288097 @default.
- W2912177640 creator A5031671812 @default.
- W2912177640 creator A5039888241 @default.
- W2912177640 creator A5053684012 @default.
- W2912177640 creator A5057445154 @default.
- W2912177640 creator A5071792050 @default.
- W2912177640 creator A5086940052 @default.
- W2912177640 date "2018-07-25" @default.
- W2912177640 modified "2023-09-26" @default.
- W2912177640 title "Clinical Experience with Perampanel in Intractable Focal Epilepsy Over 12 Months of Follow-Up" @default.
- W2912177640 cites W1498758291 @default.
- W2912177640 cites W1546717111 @default.
- W2912177640 cites W1551373999 @default.
- W2912177640 cites W1920696238 @default.
- W2912177640 cites W1993609519 @default.
- W2912177640 cites W2035775274 @default.
- W2912177640 cites W2074251342 @default.
- W2912177640 cites W2094201176 @default.
- W2912177640 cites W2135808877 @default.
- W2912177640 cites W2239645226 @default.
- W2912177640 cites W2332716921 @default.
- W2912177640 cites W2414249837 @default.
- W2912177640 cites W2512951033 @default.
- W2912177640 cites W2516670073 @default.
- W2912177640 cites W2560633658 @default.
- W2912177640 cites W2561337999 @default.
- W2912177640 cites W2613381068 @default.
- W2912177640 cites W2616216876 @default.
- W2912177640 cites W2782947102 @default.
- W2912177640 cites W2803190298 @default.
- W2912177640 doi "https://doi.org/10.14581/jer.18010" @default.
- W2912177640 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6374530" @default.
- W2912177640 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30809498" @default.
- W2912177640 hasPublicationYear "2018" @default.
- W2912177640 type Work @default.
- W2912177640 sameAs 2912177640 @default.
- W2912177640 citedByCount "10" @default.
- W2912177640 countsByYear W29121776402020 @default.
- W2912177640 countsByYear W29121776402021 @default.
- W2912177640 countsByYear W29121776402022 @default.
- W2912177640 countsByYear W29121776402023 @default.
- W2912177640 crossrefType "journal-article" @default.
- W2912177640 hasAuthorship W2912177640A5010288097 @default.
- W2912177640 hasAuthorship W2912177640A5031671812 @default.
- W2912177640 hasAuthorship W2912177640A5039888241 @default.
- W2912177640 hasAuthorship W2912177640A5053684012 @default.
- W2912177640 hasAuthorship W2912177640A5057445154 @default.
- W2912177640 hasAuthorship W2912177640A5071792050 @default.
- W2912177640 hasAuthorship W2912177640A5086940052 @default.
- W2912177640 hasBestOaLocation W29121776401 @default.
- W2912177640 hasConcept C118552586 @default.
- W2912177640 hasConcept C126322002 @default.
- W2912177640 hasConcept C141071460 @default.
- W2912177640 hasConcept C187212893 @default.
- W2912177640 hasConcept C195910791 @default.
- W2912177640 hasConcept C197934379 @default.
- W2912177640 hasConcept C2777260799 @default.
- W2912177640 hasConcept C2778186239 @default.
- W2912177640 hasConcept C2778375690 @default.
- W2912177640 hasConcept C2778562196 @default.
- W2912177640 hasConcept C2779034229 @default.
- W2912177640 hasConcept C2780820931 @default.
- W2912177640 hasConcept C2780836401 @default.
- W2912177640 hasConcept C42219234 @default.
- W2912177640 hasConcept C71924100 @default.
- W2912177640 hasConceptScore W2912177640C118552586 @default.
- W2912177640 hasConceptScore W2912177640C126322002 @default.
- W2912177640 hasConceptScore W2912177640C141071460 @default.
- W2912177640 hasConceptScore W2912177640C187212893 @default.
- W2912177640 hasConceptScore W2912177640C195910791 @default.
- W2912177640 hasConceptScore W2912177640C197934379 @default.
- W2912177640 hasConceptScore W2912177640C2777260799 @default.
- W2912177640 hasConceptScore W2912177640C2778186239 @default.
- W2912177640 hasConceptScore W2912177640C2778375690 @default.
- W2912177640 hasConceptScore W2912177640C2778562196 @default.
- W2912177640 hasConceptScore W2912177640C2779034229 @default.
- W2912177640 hasConceptScore W2912177640C2780820931 @default.
- W2912177640 hasConceptScore W2912177640C2780836401 @default.
- W2912177640 hasConceptScore W2912177640C42219234 @default.
- W2912177640 hasConceptScore W2912177640C71924100 @default.
- W2912177640 hasIssue "2" @default.
- W2912177640 hasLocation W29121776401 @default.
- W2912177640 hasLocation W29121776402 @default.
- W2912177640 hasLocation W29121776403 @default.
- W2912177640 hasLocation W29121776404 @default.
- W2912177640 hasOpenAccess W2912177640 @default.
- W2912177640 hasPrimaryLocation W29121776401 @default.
- W2912177640 hasRelatedWork W2015861704 @default.
- W2912177640 hasRelatedWork W2338450099 @default.
- W2912177640 hasRelatedWork W2419078305 @default.
- W2912177640 hasRelatedWork W2912177640 @default.
- W2912177640 hasRelatedWork W2924012904 @default.
- W2912177640 hasRelatedWork W3211205717 @default.
- W2912177640 hasRelatedWork W3211869309 @default.
- W2912177640 hasRelatedWork W4284662858 @default.
- W2912177640 hasRelatedWork W4317631169 @default.